BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15952587)

  • 21. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.
    Navakanit R; Graidist P; Leeanansaksiri W; Dechsukum C
    J Med Assoc Thai; 2007 Nov; 90(11):2416-21. PubMed ID: 18181329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials.
    Thomas M; Greil J; Heidenreich O
    Acta Pharmacol Sin; 2006 Mar; 27(3):273-81. PubMed ID: 16490161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel ex-vivo application of RNAi for neuroscience.
    Baskin L; Urschel S; Eiberger B
    Biotechniques; 2008 Sep; 45(3):338-9. PubMed ID: 18778260
    [No Abstract]   [Full Text] [Related]  

  • 27. siRNA--getting the message out.
    Lee SH; Sinko PJ
    Eur J Pharm Sci; 2006 Apr; 27(5):401-10. PubMed ID: 16442784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards therapeutic application of RNA-mediated gene regulation. Preface.
    Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):667. PubMed ID: 19389435
    [No Abstract]   [Full Text] [Related]  

  • 29. [Application of RNAi in gene-deficient models].
    Tan YL; Yin QW
    Yi Chuan Xue Bao; 2005 Apr; 32(4):434-41. PubMed ID: 16011036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatological applications of gene silencing RNA technology.
    Slater DN
    Br J Dermatol; 2011 May; 164(5):939. PubMed ID: 21518325
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of functional RNAs in human diseases].
    Tanaka Y; Kozu T
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2235-7. PubMed ID: 17471945
    [No Abstract]   [Full Text] [Related]  

  • 32. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular therapy in the microRNA era.
    Wurdinger T; Costa FF
    Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference detected 20 years ago?
    Schmidt FR
    Nat Biotechnol; 2004 Mar; 22(3):267-8. PubMed ID: 14990942
    [No Abstract]   [Full Text] [Related]  

  • 38. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [RNA interference: biology and perspectives of application in biomedicine and biotechnology].
    Vil'gel'm AE; Chumakov SP; Prasolov VS
    Mol Biol (Mosk); 2006; 40(3):387-403. PubMed ID: 16813159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The silent treatment: siRNAs as small molecule drugs.
    Dykxhoorn DM; Palliser D; Lieberman J
    Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.